glp-1 drugs and pcos Your Body Isn't Broken: How Medications Are Changing The Game For 8 Benefits of GLP‑1's Beyond

Neuropsychopharmacology 39, 22332243

The two groups of GLP-1 RAs, while sharing many similarities, present different pharmacodynamic features and, thus, yield different antidiabetic efficacy

Who are GLP-1 Users

Countries with significant sales include the United States, Canada, Mexico, the United Kingdom, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, South Africa, the United Arab Emirates, Kuwait, and Saudi Arabia [66]

The risk of MACE was reduced by 12% (HR 0.88, 95% CI 0.840.94) with GLP-1RAs and by 11% (HR 0.89, 95% CI 0.830.96) with SGLT2is compared with that in placebo groups, suggesting that GLP-1RAs and SGLT2is reduce the risk of MACE to a similar extent

They can be a good option for people who have Type 2 diabetes with an A1C level that remains persistently high despite taking other medications or for those who are obese and who have tried unsuccessfully to lose weight